among 77â€‰469 healthy adults enrolled in the nationwide population-based prospective prostate, lung, colorectal, and ovarian (plco) cancer screening trial, we identified 71 subjects who developed mm during the course of the study in whom serially collected (up to 6) prediagnostic serum samples obtained 2 to 9.8 years prior to mm diagnosis were available.